Toxicological Sciences 58, 399-415 (2000)
Copyright © 2000 by the Society of Toxicology
Safety Evaluation |
Toxicogenomics-Based Discrimination of Toxic Mechanism in HepG2 Human Hepatoma Cells
* Drug Safety Evaluation, Robert Wood Johnson Pharmaceutical Research Institute, P.O. Box 300, Route 202, Raritan, New Jersey 08869; and
Phase-1 Molecular Toxicology, Inc., Santa Fe, New Mexico 87505
The rapid discovery of sequence information from the Human Genome Project has exponentially increased the amount of data that can be retrieved from biomedical experiments. Gene expression profiling, through the use of microarray technology, is rapidly contributing to an improved understanding of global, coordinated cellular events in a variety of paradigms. In the field of toxicology, the potential application of toxicogenomics to indicate the toxicity of unknown compounds has been suggested but remains largely unsubstantiated to date. A major supposition of toxicogenomics is that global changes in the expression of individual mRNAs (i.e., the transcriptional responses of cells to toxicants) will be sufficiently distinct, robust, and reproducible to allow discrimination of toxicants from different classes. Definitive demonstration is still lacking for such specific "genetic fingerprints," as opposed to nonspecific general stress responses that may be indistinguishable between compounds and therefore not suitable as probes of toxic mechanisms. The present studies demonstrate a general application of toxicogenomics that distinguishes two mechanistically unrelated classes of toxicants (cytotoxic anti-inflammatory drugs and DNA-damaging agents) based solely upon a cluster-type analysis of genes differentially induced or repressed in cultured cells during exposure to these compounds. Initial comparisons of the expression patterns for 100 toxic compounds, using all 
250 genes on a DNA microarray ( 2.5 million data points), failed to discriminate between toxicant classes. A major obstacle encountered in these studies was the lack of reproducible gene responses, presumably due to biological variability and technological limitations. Thus multiple replicate observations for the prototypical DNA damaging agent, cisplatin, and the non-steroidal anti-inflammatory drugs (NSAIDs) diflunisal and flufenamic acid were made, and a subset of genes yielding reproducible inductions/repressions was selected for comparison. Many of the "fingerprint genes" identified in these studies were consistent with previous observations reported in the literature (e.g., the well-characterized induction by cisplatin of p53-regulated transcripts such as p21waf1/cip1 and PCNA [proliferating cell nuclear antigen]). These gene subsets not only discriminated among the three compounds in the learning set but also showed predictive value for the rest of the database ( 100 compounds of various toxic mechanisms). Further refinement of the clustering strategy, using a computer-based optimization algorithm, yielded even better results and demonstrated that genes that ultimately best discriminated between DNA damage and NSAIDs were involved in such diverse processes as DNA repair, xenobiotic metabolism, transcriptional activation, structural maintenance, cell cycle control, signal transduction, and apoptosis. The determination of genes whose responses appropriately group and dissociate anti-inflammatory versus DNA-damaging agents provides an initial paradigm upon which to build for future, higher throughput-based identification of toxic compounds using gene expression patterns alone.
Key Words: toxicogenomics; gene expression profiling; cDNA microarrays; non-steroidal anti-inflammatory agents; DNA damaging agents.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. C. M. Staal, D. S. Pushparajah, M. H. M. van Herwijnen, R. W. H. Gottschalk, L. M. Maas, C. Ioannides, F. J. van Schooten, and J. H. M. van Delft Interactions between polycyclic aromatic hydrocarbons in binary mixtures: Effects on gene expression and DNA adduct formation in precision-cut rat liver slices Mutagenesis, August 18, 2008; (2008) gen041v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Kim, D. J. Dix, K. E. Thompson, R. N. Murrell, J. E. Schmid, J. E. Gallagher, and J. C. Rockett Gene expression in head hair follicles plucked from men and women. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 115 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. C.M. Staal, M. H.M. van Herwijnen, F. J. van Schooten, and J. H.M. van Delft Modulation of gene expression and DNA adduct formation in HepG2 cells by polycyclic aromatic hydrocarbons with different carcinogenic potencies Carcinogenesis, March 1, 2006; 27(3): 646 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Waring, M. J. Liguori, J. P. Luyendyk, J. F. Maddox, P. E. Ganey, R. F. Stachlewitz, C. North, E. A. G. Blomme, and R. A. Roth Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and Neutrophils J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1080 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Boverhof and T. R. Zacharewski Toxicogenomics in Risk Assessment: Applications and Needs Toxicol. Sci., February 1, 2006; 89(2): 352 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. M. Heijne, R.-J. A. N. Lamers, P. J. van Bladeren, J. P. Groten, J. H. J. van Nesselrooij, and B. van Ommen Profiles of Metabolites and Gene Expression in Rats with Chemically Induced Hepatic Necrosis Toxicol Pathol, June 1, 2005; 33(4): 425 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Boorman, R. D. Irwin, M. K. Vallant, D. K. Gerken, E. K. Lobenhofer, M. R. Hejtmancik, P. Hurban, A. M. Brys, G. S. Travlos, J. S. Parker, et al. Variation in the Hepatic Gene Expression in Individual Male Fischer Rats Toxicol Pathol, January 1, 2005; 33(1): 102 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Morgan, Z. Jayyosi, M. A. Hower, M. V. Pino, T. M. Connolly, K. Kotlenga, J. Lin, M. Wang, H.-L. Schmidts, M. S. Bonnefoi, et al. The Hepatic Transcriptome as a Window on Whole-Body Physiology and Pathophysiology Toxicol Pathol, January 1, 2005; 33(1): 136 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. M. van Delft, E. van Agen, S. G. J. van Breda, M. H. Herwijnen, Y. C. M. Staal, and J. C. S. Kleinjans Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling Carcinogenesis, July 1, 2004; 25(7): 1265 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Jolly, R. Ciurlionis, D. Morfitt, M. Helgren, R. Patterson, R. G. Ulrich, and J. F. Waring Microvesicular Steatosis Induced by a Short Chain Fatty Acid: Effects on Mitochondrial Function and Correlation with Gene Expression Toxicol Pathol, February 1, 2004; 32(2_suppl): 19 - 25. [Abstract] [PDF]
|
|
|
|
|
|
K. T. Morgan, M. Pino, L. M. Crosby, Min Wang, T. C. Elston, Z. Jayyosi, M. Bonnefoi, and G. Boorman Complementary Roles for Toxicologic Pathology and Mathematics in Toxicogenomics, With Special Reference to Data Interpretation and Oscillatory Dynamics Toxicol Pathol, January 1, 2004; 32(1_suppl): 13 - 25. [Abstract] [PDF]
|
|
|
|
|
|
F. de Longueville, F. A. Atienzar, L. Marcq, S. Dufrane, S. Evrard, L. Wouters, F. Leroux, V. Bertholet, B. Gerin, R. Whomsley, et al. Use of a Low-Density Microarray for Studying Gene Expression Patterns Induced by Hepatotoxicants on Primary Cultures of Rat Hepatocytes Toxicol. Sci., October 1, 2003; 75(2): 378 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luhe, H. Hildebrand, U. Bach, T. Dingermann, and H.-J. Ahr A New Approach to Studying Ochratoxin A (OTA)-Induced Nephrotoxicity: Expression Profiling in Vivo and in Vitro Employing cDNA Microarrays Toxicol. Sci., June 1, 2003; 73(2): 315 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Lash, R. N. Hines, F. J. Gonzalez, T. R. Zacharewski, and M. A. Rothstein Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 403 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Rockett, R. J. Kavlock, C. R. Lambright, L. G. Parks, J. E. Schmid, V. S. Wilson, C. Wood, and D. J. Dix DNA Arrays to Monitor Gene Expression in Rat Blood and Uterus following 17{beta}-Estradiol Exposure: Biomonitoring Environmental Effects Using Surrogate Tissues Toxicol. Sci., September 1, 2002; 69(1): 49 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mohr, G. D. Leikauf, G. Keith, and B. H. Rihn Microarrays as Cancer Keys: An Array of Possibilities J. Clin. Oncol., July 15, 2002; 20(14): 3165 - 3175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Morgan, Hong Ni, H. R. Brown, L. Yoon, C. W. Qualls JR, L. M. Crosby, R. Reynolds, B. Gaskill, S. P. Anderson, T. B. Kepler, et al. Application of cDNA Microarray Technology to In Vitro Toxicology and the Selection of Genes for a Real-Time RT-PCR-Based Screen for Oxidative Stress in Hep-G2 Cells Toxicol Pathol, June 1, 2002; 30(4): 435 - 451. [Abstract] [PDF]
|
|
|
|
|
|
G. A. Boorman, S. P. Anderson, W. M. Casey, R. H. Brown, L. M. Crosby, K. Gottschalk, M. Easton, Hong Ni, and K. T. Morgan Toxicogenomics, Drug Discovery, and the Pathologist Toxicol Pathol, January 1, 2002; 30(1): 15 - 27. [Abstract] [PDF]
|
|
|
|
|
|
Q. Huang, R. T. Dunn II, S. Jayadev, O. DiSorbo, F. D. Pack, S. B. Farr, R. E. Stoll, and K. T. Blanchard Assessment of Cisplatin-Induced Nephrotoxicity by Microarray Technology Toxicol. Sci., October 1, 2001; 63(2): 196 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Casey, S. Anderson, T. Fox, K. Dold, H. Colton, and K. Morgan Transcriptional and physiological responses of HepG2 cells exposed to diethyl maleate: time course analysis Physiol Genomics, February 28, 2002; 8(2): 115 - 122. [Abstract] [Full Text] [PDF]
|
|